Can knowing you and your family may get Alzheimer’s ever be positive?
By Giulia Rhodes,
The Guardian
| 09. 21. 2015
Untitled Document
At the University of Washington’s School of Medicine there is a computer database that states with certainty – albeit heavily encrypted – whether or not Sophie Leggett will develop a form of genetically inherited early onset Alzheimer’s disease. But she has chosen not to find out what it says.
A blood test is available to adult children and siblings of those who develop Alzheimer’s at a young age and have a family history of the disease. It identifies whether they carry one of the three faulty genes known to cause familial early onset Alzheimer’s, presenilin 1 (the mutation affecting Leggett’s family), presenilin 2 and amyloid precursor protein. All result in the overproduction of amyloid, a protein that builds up into the plaques on the brain which are the hallmark of Alzheimer’s.
Now 39, Leggett saw her mother and aunt develop familial early onset Alzheimer’s in their early 40s – as had their father. All died in their 50s. There is a one-in-two chance that Leggett has inherited the gene mutation.
“I focus on the 50% chance that...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Katrina Miller, The New York TImes | 02.05.2026
Joseph Yracheta: The Native Biodata Consortium is the first nonprofit data and sample repository within the geographic bounds and legal jurisdiction of an American Indian nation, on the Cheyenne River Sioux Reservation in Eagle Butte, S.D.
NativeBio participated in a ...
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...